• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低密度脂蛋白(LDL)-甘油三酯及其与 LDL 胆固醇的比值作为非酒精性脂肪性肝炎的诊断生物标志物。

Low-Density Lipoprotein (LDL)-Triglyceride and Its Ratio to LDL-Cholesterol as Diagnostic Biomarkers for Nonalcoholic Steatohepatitis.

机构信息

Department of Gastroenterology and Hepatology, Graduate School of Medicine, Dentistry, and Pharmaceutical Science, Okayama University, Okayama, Japan.

Department of Gastroenterology, Okayama City Hospital, Okayama, Japan.

出版信息

J Appl Lab Med. 2020 Nov 1;5(6):1206-1215. doi: 10.1093/jalm/jfaa044.

DOI:10.1093/jalm/jfaa044
PMID:32674154
Abstract

BACKGROUND

Nonalcoholic fatty liver disease (NAFLD) is the most common type of liver disease, but it is difficult to distinguish its pathogenic phenotype, nonalcoholic steatohepatitis (NASH), from nonalcoholic fatty liver (NAFL) without a liver biopsy. We analyzed serum lipids, including low-density lipoprotein triglyceride (LDL-TG), to elucidate their usefulness for diagnosing NASH.

PATIENTS AND METHODS

Serum samples obtained from 35 NASH and 9 NAFL biopsy-confirmed patients and 6 healthy volunteers (HLT) were studied for 13 lipid-related markers and compared between HLT, NAFL, and NASH groups. The relationship between histological findings and the lipid markers was also analyzed.

RESULTS

There were significant differences in triglyceride, LDL-TG, the ratio of LDL-TG to the LDL-cholesterol (LDL-TG/LDL-C), small dense LDL-C, and apolipoprotein E between the three groups. Among the 5 lipid components, serum LDL-TG level and the ratio of LDL-TG to the LDL-cholesterol (LDL-TG/LDL-C) were significantly elevated in NASH. The median concentrations of LDL-TG in HLT, NAFL, and NASH were 9, 15, and 20 mg/dL (P < 0.001), and those of LDL-TG/LDL-C were 0.097, 0.102, and 0.173 (P < 0.001), respectively. Although the degree of steatosis was not correlated with the LDL-TG/LDL-C, the ratio was significantly higher in patients with lobular inflammation (P = 0.071), ballooning (P = 0.031), and fibrosis (P < 0.001). The area under the receiver operating characteristic curve of the ratio for distinguishing NASH from NAFL was 0.857. The rest of studied markers showed no significant utility.

CONCLUSION

Serum LDL-TG levels and the LDL-TG/LDL-C ratio might serve as simple and noninvasive diagnostic biomarkers for NASH.

摘要

背景

非酒精性脂肪性肝病(NAFLD)是最常见的肝病类型,但在没有肝活检的情况下,很难将其致病表型非酒精性脂肪性肝炎(NASH)与非酒精性脂肪肝(NAFL)区分开来。我们分析了血清脂质,包括低密度脂蛋白甘油三酯(LDL-TG),以阐明其在诊断 NASH 中的作用。

患者和方法

研究了 35 例 NASH 和 9 例经肝活检证实的 NAFL 患者和 6 名健康志愿者(HLT)的血清样本,检测了 13 种与脂质相关的标志物,并比较了 HLT、NAFL 和 NASH 组之间的差异。还分析了组织学发现与脂质标志物之间的关系。

结果

三组之间的甘油三酯、LDL-TG、LDL-TG 与 LDL 胆固醇(LDL-TG/LDL-C)的比值、小而密 LDL-C 和载脂蛋白 E 存在显著差异。在这 5 种脂质成分中,NASH 患者血清 LDL-TG 水平和 LDL-TG 与 LDL 胆固醇(LDL-TG/LDL-C)的比值显著升高。HLT、NAFL 和 NASH 中 LDL-TG 的中位数浓度分别为 9、15 和 20mg/dL(P<0.001),LDL-TG/LDL-C 分别为 0.097、0.102 和 0.173(P<0.001)。虽然脂肪变性程度与 LDL-TG/LDL-C 无关,但在具有小叶炎症(P=0.071)、气球样变(P=0.031)和纤维化(P<0.001)的患者中,该比值显著更高。区分 NASH 与 NAFL 的 LDL-TG/LDL-C 比值的受试者工作特征曲线下面积为 0.857。其余研究标志物均无显著作用。

结论

血清 LDL-TG 水平和 LDL-TG/LDL-C 比值可能是 NASH 的简单、无创诊断生物标志物。

相似文献

1
Low-Density Lipoprotein (LDL)-Triglyceride and Its Ratio to LDL-Cholesterol as Diagnostic Biomarkers for Nonalcoholic Steatohepatitis.低密度脂蛋白(LDL)-甘油三酯及其与 LDL 胆固醇的比值作为非酒精性脂肪性肝炎的诊断生物标志物。
J Appl Lab Med. 2020 Nov 1;5(6):1206-1215. doi: 10.1093/jalm/jfaa044.
2
[Value of serum osteoprotegerin in noninvasive diagnosis of nonalcoholic steatohepatitis].[血清骨保护素在非酒精性脂肪性肝炎无创诊断中的价值]
Zhonghua Gan Zang Bing Za Zhi. 2016 Feb;24(2):96-101. doi: 10.3760/cma.j.issn.1007-3418.2016.02.005.
3
LC-MS-based lipidomic analysis in distinguishing patients with nonalcoholic steatohepatitis from nonalcoholic fatty liver.基于 LC-MS 的脂质组学分析在鉴别非酒精性脂肪性肝炎与非酒精性脂肪肝患者中的应用。
Hepatobiliary Pancreat Dis Int. 2021 Oct;20(5):452-459. doi: 10.1016/j.hbpd.2021.05.008. Epub 2021 Jun 25.
4
Hepatic Alanine Differentiates Nonalcoholic Steatohepatitis From Simple Steatosis in Humans and Mice: A Proton MR Spectroscopy Study With Long Echo Time.肝脏丙氨酸可将人类和小鼠的非酒精性脂肪性肝炎与单纯性脂肪变性区分开来:质子磁共振波谱研究与长回波时间。
J Magn Reson Imaging. 2017 Nov;46(5):1298-1310. doi: 10.1002/jmri.25673. Epub 2017 Feb 22.
5
IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.2 型糖尿病对非酒精性脂肪性肝病患者非酒精性脂肪性肝炎和肝纤维化进展的影响。
Endocr Pract. 2020 Apr;26(4):444-453. doi: 10.4158/EP-2019-0342. Epub 2020 Jan 22.
6
Lipoprotein and Metabolic Profiles Indicate Similar Cardiovascular Risk of Liver Steatosis and NASH.脂代谢与代谢特征提示肝脂肪变性和 NASH 具有相似的心血管风险。
Digestion. 2021;102(5):671-681. doi: 10.1159/000510600. Epub 2020 Oct 20.
7
Discordant association of nonalcoholic fatty liver disease with lipoprotein(a) and markers of atherogenic dyslipidemia.非酒精性脂肪性肝病与脂蛋白(a)及动脉粥样硬化性血脂异常标志物之间的不一致关联。
J Clin Lipidol. 2023 Nov-Dec;17(6):828-833. doi: 10.1016/j.jacl.2023.09.003. Epub 2023 Nov 11.
8
Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.氧化型低密度脂蛋白抗体/高密度脂蛋白胆固醇比值与晚期非酒精性脂肪性肝病瘦患者有关。
J Gastroenterol Hepatol. 2016 Sep;31(9):1611-8. doi: 10.1111/jgh.13335.
9
Serum cytokeratin 18 fragment level as a noninvasive biomarker for non-alcoholic fatty liver disease.血清细胞角蛋白18片段水平作为非酒精性脂肪性肝病的一种非侵入性生物标志物。
Int J Clin Exp Med. 2014 Nov 15;7(11):4191-8. eCollection 2014.
10
Irisin in patients with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者的鸢尾素。
Metabolism. 2014 Feb;63(2):207-17. doi: 10.1016/j.metabol.2013.09.013. Epub 2013 Oct 18.

引用本文的文献

1
Non-Invasive Tests as a Replacement for Liver Biopsy in the Assessment of MASLD.非侵入性检测在评估代谢相关脂肪性肝病(MASLD)中替代肝活检的应用
Medicina (Kaunas). 2025 Apr 16;61(4):736. doi: 10.3390/medicina61040736.
2
Non-invasive diagnosis of non-alcoholic fatty liver disease: Current status and future perspective.非酒精性脂肪性肝病的无创诊断:现状与未来展望。
Heliyon. 2024 Feb 29;10(5):e27325. doi: 10.1016/j.heliyon.2024.e27325. eCollection 2024 Mar 15.
3
Evaluation of ABCA1 gene polymorphism as a prognostic index of fibrosis progression in NAFLD patients.
评估 ABCA1 基因多态性作为非酒精性脂肪性肝病患者纤维化进展的预后指标。
Endocrinol Diabetes Metab. 2023 Jan;6(1):e394. doi: 10.1002/edm2.394. Epub 2022 Nov 29.
4
Metabolic Properties of Lowdensity Lipoprotein (LDL) Triglycerides in Patients with Type 2 Diabetes, Comparison with Small Dense LDL-Cholesterol.2 型糖尿病患者的低密度脂蛋白(LDL)甘油三酯的代谢特性,与小而密 LDL 胆固醇的比较。
J Atheroscler Thromb. 2022 May 1;29(5):762-774. doi: 10.5551/jat.62789. Epub 2021 Apr 29.